Capital Markets - Equity CapitalThe ByrneWallace Equity Capital Markets team is one of the most highly regarded in Ireland. With excellent long-standing relationships with local finance houses, investments banks and listed companies, we offer our clients comprehensive and commercially driven solutions to address the full range of capital financing issues.
Our team has a wealth of experience advising listed companies, sponsors/nominated advisers, placing agents, investors and other stakeholders on the full spectrum of capital markets transactions and public takeovers, as well as general compliance issues and continuing obligations under stock exchange rules and the Irish Takeover Rules.
Our team also has particular experience advising boards of public companies in high profile cases in contentious scenarios including disputes with major shareholders centred on the removal of executive board members.
We operate cross-functional teams to ensure a comprehensive approach to all aspects of the transaction. We negotiate robustly on your behalf to ensure that the deal is structured to your benefit. To this end, team includes experienced lawyers from our banking, financial services, corporate, technology, intellectual property, regulatory and tax teams.
We advise domestic and international clients on a broad range of equity capital market transactions, including:
- Secondary fundraisings, rights issues and open offers
- Corporate governance and shareholder disputes
- Pre-IPO fundraisings and reorganisations
- Continuing obligations under stock exchange rules, market abuse and securities law issues
- Irish Takeovers Rules
For advice on matters relating to equity capital markets, contact Gerry Beausang, Partner, Corporate.
Advising Aminex plc on a proposed equity funding to raise up to Stg£19.5m (US$25.4m) by the issue of new shares
ByrneWallace advised dual listed oil and gas exploration and production company Aminex plc in relation to a €2.3m placing of new shares.
Nexvet Biopharma plc
Acted for Nexvet Biopharma plc in relation to its fully underwritten US$40m IPO